VKH

Objective: To investigate the present status in the diagnosis of Vogt-Koyanagi-Harada ( VKH) syndrome n China.

目的：分析我国Vogt-小柳原田（VKH）综合征临床诊断中存在的问题。

Objective The study is tried to analysis the clinical feature of Vogt-Koyanagi-Harada syndrome ( VKH) in order to make an early diagnostic of the disease.

目的探求伏格特-小柳-原田综合征（Vogt-Koyanagi-Harada Syndrome，VKH）综合征临床表现重要特征，提高早期确诊率。

Objective To detect the changes of function of blood-aqueous barrier in different Syndrome stages of patients with Vogt-Koyanagi-Harada ( VKH) syndrome in order to provide the appropriate therapy.

目的检测Vogt-小柳原田（VKH）综合征患者不同病期血-房水屏障功能变化，为临床治疗提供依据。

Objective To investigate the clinical features, treatment and prognosis of Vogt-Koyanagi-Harada ( VKH) disease.

目的探讨Vogt-小柳-原田病（Vogt-Koyanagi-Harada，VKH）的临床特点、治疗和预后等问题。

Conclusions ICGA may assist in providing valuable informations on choroidal circulation of VKH and be useful in evaluating the curative effects.

结论ICGA可较好提供VKH的脉络膜循环损害的信息，并在评价疗效上有意义。

Conclusion Prodrome, clinical course, extraocular manifestations and FFA are helpful to the diagnosis of VKH disease. Early and aggressive systemic treatment with corticosteroids has greatly improved the visual outcome in VKH patients.

结论前驱症状、临床病程、眼外表现及FFA等有助于VKH的诊断，早期给予大剂量糖皮质激素治疗，绝大部分患者可控制炎症，改善视力。

Methods: To analyze eye symptoms and FFA of 20 cases ( 40 eyes) with VKH retrospectively.

方法：对20例（40只眼）患者的眼部表现及FFA等临床资料进行回顾性分析。